Trial Profile
The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting SteNt Study: Head-to-head Comparison of Clinical Outcome After Implantation of Second Generation Drug-eluting Stents in a Real World Scenario.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Sep 2020
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary) ; Everolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms TWENTE I
- 12 Jul 2020 Results of pooled analysis from four trials (TWENTE I- TWENTE IV) published in the American Heart Journal
- 04 Sep 2013 Two-year results according to gender presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
- 09 Feb 2012 Results published in the Journal of the American College of Cardiology.